sec filing

NASDAQ · VERU
Veru Inc.
Healthcare · Biotechnology
$2.47
Down-$0.08 (-3.14%)
Updated Oct 7, 2026, 10:20 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 37.07M
- P/E ratio
- -1.13
- Dividend yield
- 0.00%
- 52-week range
- $2.05 – $7.33
- Volume
- 1.52M
- Avg. volume
- 159K
Price performance · VERU
VERU price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
VERU closed at $2.47 after 21 trading sessions, down 4.26% for the selected period.
- Last close
- $2.47
- Period change
- -4.26%
- Period low
- $2.32
- Period high
- $2.66
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $2.54 | $2.75 | $2.44 | $2.47 | 1.52M |
| Oct 5, 2026 | $2.51 | $2.62 | $2.50 | $2.55 | 88.77K |
| Oct 2, 2026 | $2.56 | $2.56 | $2.50 | $2.51 | 104.96K |
| Oct 1, 2026 | $2.65 | $2.65 | $2.53 | $2.54 | 70.68K |
| Sep 30, 2026 | $2.58 | $2.70 | $2.51 | $2.66 | 183K |
| Sep 29, 2026 | $2.53 | $2.58 | $2.50 | $2.56 | 33.1K |
| Sep 28, 2026 | $2.52 | $2.57 | $2.5102 | $2.525 | 101.37K |
| Sep 25, 2026 | $2.55 | $2.57 | $2.50 | $2.54 | 116.07K |
| Sep 24, 2026 | $2.42 | $2.52 | $2.4199 | $2.51 | 87.41K |
| Sep 23, 2026 | $2.49 | $2.51 | $2.425 | $2.46 | 94.86K |
| Sep 22, 2026 | $2.46 | $2.52 | $2.421 | $2.50 | 121.37K |
| Sep 21, 2026 | $2.44 | $2.49 | $2.43 | $2.44 | 158.32K |
| Sep 18, 2026 | $2.39 | $2.44 | $2.36 | $2.41 | 103.03K |
| Sep 17, 2026 | $2.35 | $2.4001 | $2.3489 | $2.39 | 93.92K |
| Sep 16, 2026 | $2.34 | $2.37 | $2.3112 | $2.32 | 130.34K |
| Sep 15, 2026 | $2.36 | $2.36 | $2.29 | $2.34 | 125.37K |
| Sep 14, 2026 | $2.41 | $2.44 | $2.34 | $2.34 | 210.97K |
| Sep 11, 2026 | $2.52 | $2.5299 | $2.43 | $2.44 | 245.31K |
| Sep 10, 2026 | $2.52 | $2.53 | $2.46 | $2.50 | 182.73K |
| Sep 9, 2026 | $2.59 | $2.59 | $2.48 | $2.48 | 265.75K |
| Sep 8, 2026 | $2.81 | $2.8494 | $2.55 | $2.58 | 1.34M |
Latest VERU news
The latest Smart Investors Daily articles mentioning VERU.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

